首页> 外文期刊>European archives of oto-rhino-laryngology: Official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) >Analysis of multicentricity in supraglottic laryngeal carcinoma treated with partial laryngeal surgery.
【24h】

Analysis of multicentricity in supraglottic laryngeal carcinoma treated with partial laryngeal surgery.

机译:喉部分上手术治疗声门上喉癌的多中心性分析。

获取原文
获取原文并翻译 | 示例
           

摘要

A clinicopathological analysis of multicentricity in patients treated with either supraglottic horizontal laryngectomy or supracricoid partial laryngectomy for supraglottic squamous cell carcinoma of the larynx was conducted. This study included 63 patients who underwent supracricoid partial laryngectomy or supraglottic horizontal laryngectomy for T2 or T3 supraglottic laryngeal squamous cell carcinoma. The patients were divided into two groups: Group 1 included patients with one focus of the tumor (monocentric), and Group 2 included patients who had more than one focus of the tumor (multicentric) diagnosed after pathology examination. Forty-eight (76.2 %) of the patients had one focus of the tumor (Group 1) and 15 (23.8 %) of the patients had more than one focus of the tumor (Group 2). The rates of lymph node metastasis in Group 1 and Group 2 were 12.5 and 60 %, respectively. The second focus was invasive in seven (46.6 %) of the patients, carcinoma in situ in six (40 %) of the patients, and both invasive and carcinoma in situ in two (13.3 %) patients. The overall 3- and 5-year survival rates of Groups 1 and 2 were 77.1-66.7 % and 56.2-46.7 %, respectively. With regard to survival rates, no statistically significant difference was observed between Group 1 and Group 2 (p = 0.576). The lack of statistical significance might have been associated with the low sample size. Although multicentric tumors of the supraglottic larynx have high incidence of nodal metastasis, no significant increase in the rate of recurrence was determined.
机译:进行了声门上咽喉鳞状上皮癌或声门上喉部分切除术治疗的多中心性临床病理分析。该研究包括63例行T2或T3喉上咽喉鳞状细胞癌的舌上部分喉切除或声门上水平喉切除术的患者。将患者分为两组:第1组包括一个肿瘤灶(单中心)的患者,第2组包括在病理检查后诊断出肿瘤多灶(多中心)的患者。其中有48个(76.2%)患者有一个肿瘤灶(第1组),有15个患者(23.8%)有一个以上肿瘤灶(第2组)。第1组和第2组的淋巴结转移率分别为12.5%和60%。第二个重点是侵袭性患者中有7名(46.6%),原位癌患者中有6名(40%),侵袭性和原位癌患者中有2名(13.3%)。第1组和第2组的3年和5年总生存率分别为77.1-66.7%和56.2-46.7%。关于存活率,第1组和第2组之间没有观察到统计学上的显着差异(p = 0.576)。缺乏统计意义可能与样本量少有关。尽管声门上喉的多中心肿瘤具有高的淋巴结转移率,但未发现复发率显着增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号